Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by NewBuddhaon Feb 22, 2019 10:27am

84 Views

Post# 29399300

RE:RE:RE:JUST KEEPS GETTING WORSE

Thanks Dave.. I do have a life.. and I've also got money, none of which is tied up in this piece of garbage stock. Few posts down some guy is posting the description of company operation trying to get people interested. Those so called "turn-key" greenhouses were supposed to be rented and in operation and profitable like 3 years ago. My money says they prob dont ecen have renters in there which is why you never hear about it anymore. How about the old spinoff shares of NHS from 3 years ago?... oh right also worthless garbage!! If you are getting scared for your money... put your shares up for sale at 0.03 and I will buy them from you .. final offer anyone!!??

Bullboard Posts

Victory Battery Metals acquires Utah and Saskatchewan uranium projects